New MBS item added for use of faecal calprotectin test in primary care

Impact: Economic impacts, Quality of life impacts

Description of impact

The new MBS item means that GPs can quickly and reliably differentiate between IBS and IBD without referral to a gastroenterologist. A validated IBS diagnosis (tested) in primary care is critical to patient acceptance of a diagnosis and the provision of timely and effective management. This will greatly reduce QoL for patients, and reduce referral burden to tertiary referral hospitals.
Category of impactEconomic impacts, Quality of life impacts